Gadolinium and kidney disease: are your patients at risk?
Hollister
Debra
D
DaVita Corporation, Denver, CO, USA.
D058186:Acute Kidney Injury / Q000139:chemically induced / Q000453:epidemiology; D003287:Contrast Media / Q000009:adverse effects*; D003875:Drug Eruptions / Q000453:epidemiology / Q000209:etiology; D005355:Fibrosis; D019786:Gadolinium DTPA / Q000009:adverse effects* / Q000031:analogs & derivatives; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008279:Magnetic Resonance Imaging / Q000379:methods; D012307:Risk Factors; D012449:Safety; D014481:United States / Q000453:epidemiology
D003287:Contrast Media; D019786:Gadolinium DTPA